Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Puma Biotechnology, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PBYI: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8983−6
Shares27.9M27.7M−232.9K (−0.8%)
Value$79.5M$65.5M−$14.0M (−17.6%)

New holders (8)

Institutions that held Puma Biotechnology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PBYI in Q3 2022
InstitutionSharesValue% of portfolio
AlphaCentric Advisors LLC415,000$984.0K1.01%
LSV Asset Management182,099$432.0K0.00%
Ally Bridge Group (NY) LLC64,295$152.0K0.10%
Dimensional Fund Advisors LP57,305$136.0K0.00%
Cambridge Investment Research Advisors, Inc.14,945$35.0K0.00%
Balyasny Asset Management LLC13,851$33.0K0.00%
China Universal Asset Management Co., Ltd.426$1.00K0.00%
Key Financial Inc50$00.00%

Sold out (14)

Institutions that held Puma Biotechnology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PBYI in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Voya Investment Management LLC92,237$263.0K
Algert Global LLC48,178$137.0K
Charles Schwab Investment Management Inc28,820$83.0K
State of Wyoming20,732$59.0K
HRT Financial LP18,035$51.0K
Two Sigma Securities, LLC14,156$40.0K
Jane Street Group, LLC11,076$32.0K
Mackenzie Financial Corp10,090$29.0K
Gladius Capital Management LP9,811$28.0K
Eagle Bay Advisors LLC6,500$18.5K
Captrust Financial Advisors1,500$4.00K
New York State Common Retirement Fund252$1.00K
Credit Suisse AG17$0
Ellevest, Inc.94$0